Stock Evaluator: MAIA Biotechnology, Inc. (MAIA)

MAIA Biotechnology, Inc. MAIA

$1.11 -0.03 -2.63%
November 20, 2026 2:57:28 PM EST November 10, 2021 Volume: 380,164
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD AMEX | DELAYED PRICE
SECTOR INDUSTRY
Health Care Biotechnology

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
MAIA Biotechnology, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the development of targeted immunotherapies for cancer. Its lead product Ateganosine, a telomere-targeting agent currently in clinical development to evaluate its activity in Non-Small Cell Lung Cancer (NSCLC). The company was incorporated in 2018 and is headquartered in Chicago, Illinois.

Commentary & Analysis


Financial Summary

Share Statistics MAIA Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $70.4 $212.8 20%
Shares Out (Mil) 60.9 55.2 52%
Institutional Ownership 68.8% 93.3% 42%
Float (Mil) 56.1 40.8 49%
Beta 0.30 1.03 17%
Avg Daily Volume (000s) 744 559 64%
Price Change
(52-week)
12.9% 40.3% 64%
Growth MAIA Industry
Median
Percentile
(All Stocks)
Sales (5yr) na 13.6% na
Net Income (5yr) (27.7%) (10.5%) 15%
EPS (5yr) 14.2% 15.4% 55
Dividends (5yr) na 0.0% na
Cash Flow (5yr) 34.0% (15.7%) 88%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 2 2 1
Current EPS ($0.135) ($0.540) ($0.480)
Month Ago EPS ($0.140) ($0.540) $1.110
# Rev Up 0 1 0
# Rev Down 1 0 0
Three Months Ago EPS ($0.140) ($0.540) $1.110
Year/Year Chg 14.4% (22.5%) na
Financials MAIA Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) na $40 na
Net Income (TTM) (Mil) ($25) ($44) 22%
EPS (TTM) ($0.492) ($1.400) 27%
Operating Cash Flow (TTM) (Mil) ($25) ($34) 14%
Net Cash Flow (TTM) (Mil) na $-0 na
Long-Term Debt (Q1) (Mil) $0 $4 0%
Enterprise Value (Q1) (Mil) $41 $142 16%
Valuation MAIA Industry
Median
Percentile
(All Stocks)
P/B 4.75 1.97 81%
P/E na 16.8 na
Dividend Yield na 0.0% na
PEG (5yr hist) na 0.8 na
Ratios MAIA Industry
Median
Percentile
(All Stocks)
Gross Margin na 67.6% na
Net Margin na (50.8%) na
ROA (148.3%) (47.4%) 3%
ROE (341.5%) (51.4%) 2%
Liabilities to Assets 33.6% 29.6% 25%
F-Score 2 3 7%

Passing Stock Screens

As of 11/19/2026, from a list of 60 stock screening strategies, MAIA meetings the criteria of 1 screen:

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors